EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C51H79NO13 |
| Net Charge | 0 |
| Average Mass | 914.187 |
| Monoisotopic Mass | 913.55514 |
| SMILES | [H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(\C)[C@@H](OC)C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)CC[C@@H](O)[C@H](OC)C1 |
| InChI | InChI=1S/C51H79NO13/c1-30-16-12-11-13-17-31(2)42(61-8)28-38-21-19-36(7)51(60,65-38)48(57)49(58)52-23-15-14-18-39(52)50(59)64-43(33(4)26-37-20-22-40(53)44(27-37)62-9)29-41(54)32(3)25-35(6)46(56)47(63-10)45(55)34(5)24-30/h11-13,16-17,25,30,32-34,36-40,42-44,46-47,53,56,60H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12+,31-17+,35-25+/t30-,32-,33-,34-,36-,37+,38+,39+,40-,42+,43+,44-,46-,47+,51-/m1/s1 |
| InChIKey | QFJCIRLUMZQUOT-HPLJOQBZSA-N |
| Wikipedia |
|---|
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Streptomyces hygroscopicus (ncbitaxon:1912) | - | PubMed (21438579) |
| Roles Classification |
|---|
| Biological Roles: | anticoronaviral agent Any antiviral agent which inhibits the activity of coronaviruses. antibacterial drug A drug used to treat or prevent bacterial infections. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. mTOR inhibitor A protein kinase inhibitor of the mammalian target of rapamycin (mTOR), a protein that regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis and transcription. mTOR inhibitors are used to prevent transplant rejection and in treatment of cancer. bacterial metabolite Any prokaryotic metabolite produced during a metabolic reaction in bacteria. antifungal drug Any antifungal agent used to prevent or treat fungal infections in humans or animals. antifungal agent An antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce. antifungal agent An antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce. |
| Applications: | antibacterial drug A drug used to treat or prevent bacterial infections. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. geroprotector Any compound that supports healthy aging, slows the biological aging process, or extends lifespan. antifungal drug Any antifungal agent used to prevent or treat fungal infections in humans or animals. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| sirolimus (CHEBI:9168) has role antibacterial drug (CHEBI:36047) |
| sirolimus (CHEBI:9168) has role anticoronaviral agent (CHEBI:149553) |
| sirolimus (CHEBI:9168) has role antineoplastic agent (CHEBI:35610) |
| sirolimus (CHEBI:9168) has role bacterial metabolite (CHEBI:76969) |
| sirolimus (CHEBI:9168) has role geroprotector (CHEBI:176497) |
| sirolimus (CHEBI:9168) has role immunosuppressive agent (CHEBI:35705) |
| sirolimus (CHEBI:9168) has role mTOR inhibitor (CHEBI:68481) |
| sirolimus (CHEBI:9168) is a antibiotic antifungal drug (CHEBI:87113) |
| sirolimus (CHEBI:9168) is a cyclic acetal (CHEBI:59770) |
| sirolimus (CHEBI:9168) is a cyclic ketone (CHEBI:3992) |
| sirolimus (CHEBI:9168) is a ether (CHEBI:25698) |
| sirolimus (CHEBI:9168) is a macrolide lactam (CHEBI:145565) |
| sirolimus (CHEBI:9168) is a organic heterotricyclic compound (CHEBI:26979) |
| sirolimus (CHEBI:9168) is a secondary alcohol (CHEBI:35681) |
| Incoming Relation(s) |
| everolimus (CHEBI:68478) has functional parent sirolimus (CHEBI:9168) |
| ridaforolimus (CHEBI:82677) has functional parent sirolimus (CHEBI:9168) |
| IUPAC Name |
|---|
| (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone |
| INNs | Source |
|---|---|
| sirolimus | WHO MedNet |
| sirolimús | WHO MedNet |
| sirolimus | WHO MedNet |
| sirolimusum | WHO MedNet |
| Synonyms | Source |
|---|---|
| Sirolimus | KEGG COMPOUND |
| (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone | IUPAC |
| (-)-Rapamycin | ChemIDplus |
| Antibiotic AY 22989 | DrugBank |
| rapamycin | ChEBI |
| Brand Name | Source |
|---|---|
| Rapamune | DrugBank |
| Manual Xrefs | Databases |
|---|---|
| C07909 | KEGG COMPOUND |
| DB00877 | DrugBank |
| D00753 | KEGG DRUG |
| LMPK06000003 | LIPID MAPS |
| Rapamycin | Wikipedia |
| HMDB0015015 | HMDB |
| C00018055 | KNApSAcK |
| RAP | PDBeChem |
| 2446 | DrugCentral |
| Registry Numbers | Sources |
|---|---|
| Reaxys:5848501 | Reaxys |
| CAS:53123-88-9 | KEGG COMPOUND |
| CAS:53123-88-9 | ChemIDplus |
| Citations |
|---|